Pulse Biosciences, Inc.
PLSE· Nasdaq
PLSEPulse Biosciences, Inc.
Filed Aug 8, 2019 · 10-Q · 39 days after period end · 0001625101-19-000029
| Metric | Q2 2019 | Q2 2018 | Q2 2017 | Q2 2016 |
|---|---|---|---|---|
| Net Income | -$11.36M | -$9.16M | -$6.18M | -$2.26M |
| EPS Diluted | -$0.55 | -$0.54 | -$0.43 | -$0.23 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Pulse Biosciences, Inc. · CIK 1625101 · Engraved from SEC EDGAR
ended Jun 30, 2019 · filed Aug 8, 2019 · 39 d after period end
